Skip to content

Released Feb 21, 2013

10-K filed Feb 21, 2013, 52 days after period end · 0001047469-13-001388

Q4 2012 · 10-K
Revenue$26.98M−16.1% vs Q4 2011−72.0% vs Q3 2012
Net income—
EPS Diluted-$0.41N/M vs Q4 2011N/M vs Q3 2012
Operating Incomederived-$43,900,000N/M
Operating Cash Flowderived-$22,459,000N/M
Free Cash Flowderived-$25,843,000N/M
Margins · derived
Operating margin-162.7%−140.8 pt vs Q4 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2012Q4 2011Q4 2010
Revenue$26.98M$32.15M$16.77M
Net Income—-$6.97M-$11.65M
EPS Diluted-$0.41-$0.07-$0.12

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR